AusBiotech International Conference 2025 Conference AusBiotech International Conference 2025 Certara2025 年 7 月 25 日
ADNCA explained: The next generation of non-compartmental analysis and the top questions answered Blog ADNCA 解析:下一代非房室分析及其核心问题解答 ADNCA is transforming non-compartmental analysis by standardizing workflows, enhancing regulatory confidence, and enabling scalable automation.…Certara2025 年 7 月 23 日
MIDD can ease pediatric & rare disease drug loss in Japan Blog MIDD 可缓解日本儿科及罕见疾病药物短缺问题 Certara tackles pediatric cancer and rare disease drug loss in Japan by advocating MIDD, which…Certara2025 年 7 月 8 日
Accelerating Oncology Drug FDA RTOR Submission with Project Management Services Case Study 通过项目管理服务加速肿瘤药物 FDA RTOR 申报流程 Discover how Certara’s dedicated project management and pharmacometric support helped an emerging biotech company fast-track…Certara2025 年 7 月 2 日
How Model-informed drug development rescue projects from a risky situation Case Study 如何通过模型引导的药物开发助力项目从高风险局面中脱困 Discover how Certara’s integrated approach to model-informed drug development helps clients navigate regulatory challenges, achieve…Certara2025 年 6 月 26 日
From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara On-Demand Webinar 从数据到决策:基于模型的荟萃分析(MBMA)与 GSK 和 Certara 真实世界影响 Discover the Real-World Impact of Model-Based Meta-Analysis. Hear from experts, see case studies to advance…Certara2025 年 6 月 18 日
Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis On-Demand Webinar 革新传统 NCA 流程:ADNCA 技术助力合规化药代动力学分析 Certara2025 年 6 月 11 日
Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer Publication Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer The study, published in the Journal of Clinical Pharmacology, evaluates the cardiac safety of fruquintinib,…Certara2025 年 6 月 8 日
Pharmacokinetic Modeling of Neutralizing ADA Effects in Translational Development On-Demand Webinar 中和性抗糖尿病药物(ADA)效应的药代动力学建模在转化医学中的应用 Certara2025 年 5 月 21 日
Explore First: How a Stepwise Approach to QTc Studies Reduces Time, Cost, and Regulatory Risk On-Demand Webinar 探索先行:分阶段 QTc 研究策略如何减少时间、成本及监管风险 Learn how a stepwise C-QTc approach can streamline cardiac safety evaluation, reduce costs, and align…Certara2025 年 5 月 5 日